Page 17 – Redenlab

Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Posted on June 12, 2024
by Gloria Macan
Blog, Clinical Study, Dementia, Publications

Frontotemporal Dementia (FTD) encompasses a range of progressive neurodegenerative conditions that impair speech production and comprehension, higher cognitive functions, behavior, and motor skills. Considerable research has focused on conventional acoustic speech markers in FTD, as…

Posted on June 17, 2024
by Gloria Macan
Blog, clinical trials, multiple sclerosis, Publications

Up to half of all people with multiple sclerosis experience communication difficulties due to dysarthria, a disorder that impacts the motor aspects of speech production. Dysarthria in multiple sclerosis is linked to cerebellar dysfunction, disease…

Posted on June 21, 2024
by Gloria Macan
Artificial Intelligence, Blog, Clinical Study, clinical trials, News, Publications

In this study, Thayabaran Kathiresan, Redenlab’s Director of Audio Engineering, co-authors "Cortical-striatal brain network distinguishes deepfake from real speaker identity”. This study reveals that while deepfakes can partly deceive human cognition, a distinct cortical-striatal brain…

Posted on July 2, 2024
by Gloria Macan
Blog, clinical trials, Events, News

This video features an interview hosted by Global Health Youth Connect with Professor Adam Vogel called Interview with Experts.The conversation covers various topics related to his research, including the neurological basis of speech disorders, advancements…

Posted on July 14, 2024
by Gloria Macan
Blog, Clinical trial/studies, Language, Publications, Speech

Communication is essential for both daily living and achieving a successful, fulfilling life. Speech and language skills are governed by extensive and intricate brain networks, making communication disorders common in neurogenetic conditions and even minor…

Posted on September 3, 2024
by Gloria Macan
Blog, Dementia, Events, Upcoming Events

Redenlab is proud to announce our participation in the 14th International Conference on Frontotemporal Dementias (ICFTD), to be held in Amsterdam, The Netherlands, from September 19 - 22, 2024. Dr. Adam Vogel and his colleagues…

Posted on September 4, 2024
by Gloria Macan
Blog, Events, Upcoming Events

Dr. Adam Vogel, CSO of Redenlab, will be speaking alongside Dr. Tairmae Kangarloo, Associate Director of Digital Strategy at Takeda, on the topic of “Remote Monitoring of Speech and Voice as Clinical Markers of Health”…

Posted on October 14, 2024
by Gloria Macan
Blog, Events, Upcoming Events

Redenlab is pleased to announce that Dr. Adam Vogel, an expert in speech and language function, will be presenting at the 2nd Annual Lysosomal Disease Summit, held at the Pullman & Mercure Melbourne Albert Park,…

Posted on October 31, 2024
by Redenlab
Blog, Clinical trial/studies, Language, multiple sclerosis, Publications, Speech

Remote speech tests can complement in-clinic exams to help guide treatment for Multiple Sclerosis (MS). Previous studies suggested that speech patterns could indicate MS progression. In this study, speech from MS patients was recorded at…

Posted on November 12, 2024
by Redenlab
Ataxia, Blog, Events, Upcoming Events

Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research in London on November 14, 2024. He’ll be joining leading experts in a workshop centered…

Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Volumetric and diffusion MRI abnormalities associated with dysarthria in multiple sclerosis

Cortical-striatal brain network distinguishes deepfake from real speaker identity

Interview with Experts (2022) | Professor Adam Vogel

Speech and language classification in the human phenotype ontology

Redenlab at the 14th International Conference on Frontotemporal Dementias (ICFTD), 19 – 22 September 2024

Redenlab at the Digital Health and AI Innovation Summit 2024

Redenlab at the 2nd Annual Lysosomal Disease Summit 2024

Longitudinal objective assessment of speech in Multiple Sclerosis

International Congress for Ataxia Research 2024

Categories